← Leaderboards
Jeffrey Y Wong
University Of Southern California
$938,530
Attributed
$938,530
Total exposure
17
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $116.3K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$938,530 · 17
By mechanism
M01$938,530 · 17
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Richard N. Bergman$24,561,906
- Peter Cawood Butler$14,117,119
- Richard James Cote$13,022,506
- Casey M Donovan$1,549,918
- Jang H. Youn$3,326,907
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectCarcinoembryonal AntigenHuman Therapy EvaluationClinical Trial Phase IYttriumCombination Cancer TherapyAntitumor AntibodyPharmacokineticsNeoplasm /Cancer Radiation TherapyImmunoconjugatesAdult Human (21+)Neoplasm /Cancer ImmunotherapyDrug Screening /EvaluationChimeric ProteinsInjection /InfusionGrantInstitutionSourceFundingResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseResourcesUnited States National Institutes Of Health
Grant awards (31)
A PHASE I STUDY OF A COMBINATION OF YTTRIUM-90 LABELED HUMANIZED ANTI-CEA M5A$20,871
M01 · FY2009 · RR · contact PI
A PHASE I TRIAL OF RADIOIMMUNOTHERAPY (Y-90 CT8466), GEMCITABINE AND HEPATIC$6,957
M01 · FY2009 · RR · contact PI
A PHASE I STUDY OF A COMBINATION OF YTTRIUM-90 LABELED HUMANIZED ANTI-CEA M5A$22,832
M01 · FY2008 · RR · contact PI
A PHASE I TRIAL OF RADIOIMMUNOTHERAPY (Y-90 CT8466), GEMCITABINE AND HEPATIC$20,431
M01 · FY2008 · RR · contact PI
A PHASE I TRIAL OF RADIOIMMUNOTHERAPY (Y-90-MX-DTPA-CT8466) COMBINED WITH$3,605
M01 · FY2008 · RR · contact PI
PRE-SURGICAL DETECTION OF COLORECTAL CARCINOMAS USING INDIUM-DOTA-CT8466 MINIBO$103,696
M01 · FY2007 · RR · contact PI
A PHASE I TRIAL OF RADIOIMMUNOTHERAPY (Y-90 CT8466), GEMCITABINE AND HEPATIC$10,661
M01 · FY2007 · RR · contact PI
A PHASE I TRIAL OF RADIOIMMUNOTHERAPY (Y-90-MX-DTPA-CT8466) COMBINED WITH$1,939
M01 · FY2007 · RR · contact PI
PRE-SURGICAL DETECTION OF COLORECTAL CARCINOMAS USING INDIUM-DOTA-CT8466$78,386
M01 · FY2006 · RR · contact PI
A PHASE I TRIAL OF INTRAPERITONEALLY ADMINISTERED Y-90 CHIMERIC T8466 ANTI-CEA$13,064
M01 · FY2006 · RR · contact PI
A PHASE I TRIAL OF RADIOIMMUNOTHERAPY (Y-90 CT8466), GEMCITABINE AND HEPATIC$3,266
M01 · FY2006 · RR · contact PI
A PHASE I TRIAL OF INTRAPERITONEALY ADMINISTERED Y-90 CHIMERIC T8466 ANTI-CEA$11,364
M01 · FY2005 · RR
A Phase I Trial of Intraperitonealy administered Y-90$34,234
M01 · FY2004 · RR
A Phase I Trial of Liver RIT$24,606
M01 · FY2004 · RR
Pre-Surgical Detection of GI Carcinomas Using 123Iodine$7,487
M01 · FY2004 · RR
A Pilot Imaging/Biodistribution Trial$1,180
M01 · FY2004 · RR
5 FU &Y 90 IN CEA PRODUCING COLORECTAL CANCER$0
M01 · FY2002 · RR
Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY IN ADVANCE CEA PRODUCING MALIG$0
M01 · FY2002 · RR
Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY G CSF, STEM CELL SUPPORT IN BREAST CANCER$0
M01 · FY2002 · RR
5 FU &Y 90 IN CEA PRODUCING COLORECTAL CANCER$155,764
M01 · FY2001 · RR
Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY IN ADVANCE CEA PRODUCING MALIG$155,764
M01 · FY2001 · RR
Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY G CSF, STEM CELL SUPPORT IN BREAST CANCER$155,764
M01 · FY2001 · RR
Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY IN ADVANCE CEA PRODUCING MALIG$0
M01 · FY2001 · RR
Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY G CSF, STEM CELL SUPPORT IN BREAST CANCER$0
M01 · FY2001 · RR
5 FU &Y 90 IN CEA PRODUCING COLORECTAL CANCER$0
M01 · FY2001 · RR
Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY IN ADVANCE CEA PRODUCING MALIG$35,553
M01 · FY2000 · RR
Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY G CSF, STEM CELL SUPPORT IN BREAST CANCER$35,553
M01 · FY2000 · RR
5 FU &Y 90 IN CEA PRODUCING COLORECTAL CANCER$35,553
M01 · FY2000 · RR
Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY IN ADVANCE CEA PRODUCING MALIG$0
M01 · FY2000 · RR
Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY G CSF, STEM CELL SUPPORT IN BREAST CANCER$0
M01 · FY2000 · RR
5 FU &Y 90 IN CEA PRODUCING COLORECTAL CANCER$0
M01 · FY2000 · RR